Nu Skin Enterprises Inc (NUS)
Return on equity (ROE)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 8,595 | 58,528 | 70,093 | 77,438 | 104,778 | 38,332 | 113,451 | 138,552 | 147,266 | 229,964 | 236,542 | 219,055 | 191,355 | 158,000 | 145,783 | 150,281 | 173,553 | 115,682 | 124,738 | 129,350 |
| Total stockholders’ equity | US$ in thousands | 821,968 | 822,187 | 895,345 | 892,970 | 897,296 | 841,934 | 941,035 | 934,200 | 912,772 | 936,477 | 917,826 | 871,474 | 894,271 | 827,473 | 792,012 | 800,498 | 875,289 | 845,800 | 834,950 | 811,195 |
| ROE | 1.05% | 7.12% | 7.83% | 8.67% | 11.68% | 4.55% | 12.06% | 14.83% | 16.13% | 24.56% | 25.77% | 25.14% | 21.40% | 19.09% | 18.41% | 18.77% | 19.83% | 13.68% | 14.94% | 15.95% |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $8,595K ÷ $821,968K
= 1.05%
Nu Skin Enterprises, Inc.'s return on equity (ROE) has exhibited some fluctuations over the past eight quarters. In Q1 2022, the ROE was relatively high at 14.83%, indicating that the company was generating a solid return on shareholders' equity at that time. However, the ROE declined in subsequent quarters and reached its lowest point in Q4 2023 at 1.05%.
The downward trend in ROE from Q1 2022 to Q4 2023 suggests that Nu Skin Enterprises may have faced challenges in efficiently utilizing its shareholders' equity to generate profits during that period. It is essential for investors to closely monitor the company's ability to improve its ROE metric in upcoming quarters to ensure sustainable growth and profitability.
Overall, the fluctuating ROE values for Nu Skin Enterprises highlight the importance of assessing the company's performance and financial health through consistent analysis of key financial ratios.
Peer comparison
Dec 31, 2023